GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novan Inc (OTCPK:NOVNW) » Definitions » GF Value

Novan (NOVNW) GF Value : $0.00 (As of Apr. 15, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Novan GF Value?

As of today (2025-04-15), Novan's share price is $0.0004. Novan's GF Value is $0.00. Therefore, Novan's Price-to-GF-Value for today is . Based on the relationship between the current stock price and the GF Value, GuruFocus believes Novan is Not Valued.

The GF Value represents the intrinsic value of a stock, determined using GuruFocus' proprietary methodology. The GF Value Line on our stock Summary page provides an estimate of the stock’s fair-trading value.

To calculate this value, GuruFocus follows these steps:

  1. We analyze historical correlations between the stock price and key business performance metrics, such as revenue, earnings, cash flow, and book value.
  2. We identify the metrics that have the strongest historical correlation with the stock price and determine the historical multiples at which the stock has traded relative to these metrics.
  3. Using these historical multiples as a reference, we estimate the stock's fair value while accounting for future business growth. Adjustments may be made based on the company’s past returns and growth trends.

GuruFocus believes that the GF Value Line represents the fair value at which a stock should trade. Stock prices typically fluctuate around this line. If a stock’s price is significantly above the GF Value Line, it is considered overvalued, and its future returns are likely to be lower. Conversely, if the stock price is significantly below the GF Value Line, its future returns are likely to be higher.


Novan  (OTCPK:NOVNW) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 ratings:

Posssible Evaluations All-in-One Screener Examples (1)
Possible Value Trap, Think TwicePredictable Companies that possibly be Value Traps
Significantly OvervaluedPredictable Companies which are Significantly Overvalued
Modestly OvervaluedPredictable Companies which are Modestly Overvalued
Fairly ValuedPredictable High Quality Companies which are Fairly Valued
Modestly Undervalued (2)Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (2)Predictable High Quality Companies which are Significantly Undervalued

(1) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(2) A sufficient margin of safety exists only when the stock is undervalued.


Possible Value Trap, Think Twice companies are those that appear significantly undervalued based on their Price-to-GF-Value ratio, but whose fundamentals show signs of weakness.

Indicators that a company may be a value trap include:

    * Deteriorating Financial Health: A low Altman Z-scores indicates a higher risk of bankruptcy, or a low Piotroski F-Score.
    * Earnings Manipulation: A high Beneish M-score indicates potential earnings manipulation, raising concerns about the reliability of reported financials.
    * Stagnant or Declining Growth: Lack of revenue or earnings growth, or a recent slowdown, may signal limited future prospects.

Investors should conduct thorough due diligence, examining financial statements and growth indicators, to avoid falling into value traps.


Novan's Price-to-GF-Value for today is calculated as

Price-to-GF-Value=Share Price/GF Value
=0.0004/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novan GF Value Related Terms

Thank you for viewing the detailed overview of Novan's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Novan Business Description

Traded in Other Exchanges
N/A
Address
P.O. Box 64, Pittsboro, NC, USA, 27312
NVN Liquidation Inc Formerly Novan Inc is a dermatology company focused on developing and commercializing therapeutic products for skin diseases. It is developing SB206 as a topical prescription gel for the treatment of viral skin infections. The company's product portfolio includes; Wynzora Cream for the treatment of plaque psoriasis, Rhofade cream for the treatment of persistent facial erythema, Minolira tablets to treat inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients, Cloderm cream for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, Sitavig tablets for the treatment of recurrent herpes labialis in immunocompetent adults, and Nuvail nail solution for managing signs and symptoms of nail dystrophy.

Novan Headlines

From GuruFocus

Novan Inc SB206 Clinical Data Update Call Transcript

By GuruFocus Research 02-14-2024

Novan Announces Closing of $6.0 Million Registered Direct Offering

By sperokesalga sperokesalga 03-17-2023

Q4 2021 Novan Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2021 Novan Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2022 Novan Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

Novan to Report First Quarter 2023 Financial Results on May 15, 2023

By sperokesalga sperokesalga 05-08-2023

Novan Inc To Host Analyst and Investor Event Transcript

By GuruFocus Research 02-14-2024

Q2 2021 Novan Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

Novan Inc To Acquire EPI Health LLC Call Transcript

By GuruFocus Research 02-14-2024